Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine: Brian Alexander

Foundation Medicine announced that Brian Alexander, the company's chief medical officer, would take over as CEO for Cindy Perettie. Perettie has taken on a new role at Roche Diagnostics, the company said.

Alexander joined FMI as senior VP of clinical development in 2018 and was promoted to CMO in 2019. As CMO, Alexander has expanded the company's molecular tumor board program and launched a genomics and health disparities effort, the company said.

Alexander has served as a radiation oncologist at the Dana-Farber Cancer Institute and Brigham and Women's Cancer Center and an associate professor at Harvard Medical School. He is an affiliated researcher at the Massachusetts Institute of Technology's Laboratory for Financial Engineering and affiliated faculty at the Harvard Kennedy School Healthcare Policy Program. 

He was the founding director of the Program in Regulatory Science at Dana-Farber and the Harvard/MIT Center for Regulatory Science. He also cofounded the nonprofit Global Coalition for Adaptive Research and served as a White House fellow and special assistant to the Secretary of Veterans Affairs.  

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more